During this process, 17β-estradiol suppressed macrophage activation and HCC development alternatively by inhibiting the interaction between ERβ and ATPase coupling factor 6 (ATP5J, an ATPase component), and then blocking the JAK1-STAT6 signaling pathway [137]. This evidence concerns the gene ESR2 and hepatocellular carcinoma.